Home DailyMed e28b51f1-1ccf-4e42-9e49-26e48d7fa839 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:55:59
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N200603-001 LATUDA LURASIDONE HYDROCHLORIDE 40MG TABLET / ORAL AB RLD, RS 2010-10-28 N200603-002 LATUDA LURASIDONE HYDROCHLORIDE 80MG TABLET / ORAL AB RLD 2010-10-28 N200603-003 LATUDA LURASIDONE HYDROCHLORIDE 20MG TABLET / ORAL AB RLD 2011-12-07 N200603-004 LATUDA LURASIDONE HYDROCHLORIDE 120MG TABLET / ORAL AB RLD 2012-04-26 N200603-005 LATUDA LURASIDONE HYDROCHLORIDE 60MG TABLET / ORAL AB RLD 2013-07-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 55 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 215 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 84e616aacf4f…2026-08-18 06:07:40 2026-07 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-001 LATUDA 40MG TABLET / ORAL AB RLD, RS 2010-10-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-002 LATUDA 80MG TABLET / ORAL AB RLD 2010-10-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-003 LATUDA 20MG TABLET / ORAL AB RLD 2011-12-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-004 LATUDA 120MG TABLET / ORAL AB RLD 2012-04-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N200603-005 LATUDA 60MG TABLET / ORAL AB RLD 2013-07-12 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 6 · 215 observed states.
Observed Orange Book patent history# Patent history page 1 of 85 · 3,385 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N200603-001 8729085 2026-05-26 Drug product 2014-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 8883794 2026-05-26 Drug product 2014-11-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 9555027 2026-05-26 U-543 Drug product 2017-03-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 9907794 2026-05-26 Drug product 2018-03-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 8729085*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 8883794*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 9907794*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 9259423 2031-05-23 U-1822 2016-03-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 9827242 2031-05-23 U-2199 2017-12-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 9827242 2031-05-23 U-2201 2017-12-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-001 9259423*PED 2031-11-23 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 8729085 2026-05-26 Drug product 2014-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 8883794 2026-05-26 Drug product 2014-11-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 9555027 2026-05-26 U-543 Drug product 2017-03-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 9907794 2026-05-26 Drug product 2018-03-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 8729085*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 8883794*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 9907794*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 9259423 2031-05-23 U-1822 2016-03-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 9827242 2031-05-23 U-2201 2017-12-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 9827242 2031-05-23 U-2199 2017-12-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-002 9259423*PED 2031-11-23 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 8729085 2026-05-26 Drug product 2014-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 8883794 2026-05-26 Drug product 2014-11-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 9555027 2026-05-26 U-543 Drug product 2017-03-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 9907794 2026-05-26 Drug product 2018-03-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 8729085*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 8883794*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 9907794*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 9259423 2031-05-23 U-1822 2016-03-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 9827242 2031-05-23 U-2199 2017-12-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 9827242 2031-05-23 U-2201 2017-12-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-003 9259423*PED 2031-11-23 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 8729085 2026-05-26 Drug product 2014-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 8883794 2026-05-26 Drug product 2014-11-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 9555027 2026-05-26 U-543 Drug product 2017-03-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 9907794 2026-05-26 Drug product 2018-03-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 8729085*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 8883794*PED 2026-11-26 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N200603-004 9907794*PED 2026-11-26 Pediatric extension 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 120 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Latuda LURASIDONE HYDROCHLORIDE Sumitomo Pharma America, Inc. afad3051-9df2-4c54-9684-e8262a133af8 2025-01-31 Boxed warning, Warnings, Adverse reactions Exact identifier ndc (package): 63402-308-01 ndc11 (package): 63402030801
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.